JP2017508796A5 - - Google Patents

Download PDF

Info

Publication number
JP2017508796A5
JP2017508796A5 JP2016573684A JP2016573684A JP2017508796A5 JP 2017508796 A5 JP2017508796 A5 JP 2017508796A5 JP 2016573684 A JP2016573684 A JP 2016573684A JP 2016573684 A JP2016573684 A JP 2016573684A JP 2017508796 A5 JP2017508796 A5 JP 2017508796A5
Authority
JP
Japan
Prior art keywords
optionally substituted
alkyl
substituted
compound
iron
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016573684A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017508796A (ja
JP6741343B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2015/018886 external-priority patent/WO2015134710A1/en
Publication of JP2017508796A publication Critical patent/JP2017508796A/ja
Publication of JP2017508796A5 publication Critical patent/JP2017508796A5/ja
Application granted granted Critical
Publication of JP6741343B2 publication Critical patent/JP6741343B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016573684A 2014-03-07 2015-03-05 プロペラン誘導体および合成 Expired - Fee Related JP6741343B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201461949733P 2014-03-07 2014-03-07
US61/949,733 2014-03-07
PCT/US2015/018886 WO2015134710A1 (en) 2014-03-07 2015-03-05 Propellane derivates and synthesis

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2020038074A Division JP2020094059A (ja) 2014-03-07 2020-03-05 プロペラン誘導体および合成

Publications (3)

Publication Number Publication Date
JP2017508796A JP2017508796A (ja) 2017-03-30
JP2017508796A5 true JP2017508796A5 (https=) 2018-04-12
JP6741343B2 JP6741343B2 (ja) 2020-08-19

Family

ID=54055863

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2016573684A Expired - Fee Related JP6741343B2 (ja) 2014-03-07 2015-03-05 プロペラン誘導体および合成
JP2020038074A Withdrawn JP2020094059A (ja) 2014-03-07 2020-03-05 プロペラン誘導体および合成

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2020038074A Withdrawn JP2020094059A (ja) 2014-03-07 2020-03-05 プロペラン誘導体および合成

Country Status (8)

Country Link
US (1) US10654812B2 (https=)
EP (1) EP3114107B1 (https=)
JP (2) JP6741343B2 (https=)
KR (1) KR102401840B1 (https=)
CN (2) CN113336653A (https=)
CA (1) CA2942144C (https=)
TW (1) TWI671281B (https=)
WO (1) WO2015134710A1 (https=)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102243637B1 (ko) 2013-03-14 2021-04-26 리커리엄 아이피 홀딩스, 엘엘씨 바이사이클릭 진통 화합물
CN108947867A (zh) 2013-12-12 2018-12-07 卡利拉制药公司 双环烷基化合物及合成
CA2942144C (en) 2014-03-07 2023-08-22 Kalyra Pharmaceuticals, Inc. Propellane derivates and synthesis
CN106999451B (zh) * 2014-09-17 2021-04-02 里科瑞尔姆Ip控股有限责任公司 双环化合物
KR101974793B1 (ko) 2015-07-06 2019-05-02 길리애드 사이언시즈, 인코포레이티드 Cot 조정제 및 그의 사용 방법
KR102444836B1 (ko) 2016-08-23 2022-09-19 리커리엄 아이피 홀딩스, 엘엘씨 교차 커플링 방법
JP7128816B2 (ja) 2016-12-08 2022-08-31 ボード オブ レジェンツ,ザ ユニバーシティ オブ テキサス システム 疾患の治療のための二重ロイシンジッパー(dlk)キナーゼのビシクロ[1.1.1]ペンタン阻害剤
EP3628043A4 (en) 2017-05-15 2021-04-28 Recurium IP Holdings, LLC ANALGESIC COMPOUNDS
SG11202001733VA (en) * 2017-09-11 2020-03-30 Recurium Ip Holdings Llc Continuous flow processes for making bicyclic compounds
US20190382396A1 (en) * 2018-06-13 2019-12-19 Board Of Regents, The University Of Texas System Salts of bicyclo[1.1.1]pentane inhibitors of dual leucine zipper (dlk) kinase for the treatment of disease
CN109456332B (zh) * 2018-08-16 2021-11-26 北京理工大学 一种稳定的氮杂[3.3.3]螺桨烷卡宾及其制备方法
TWI770527B (zh) 2019-06-14 2022-07-11 美商基利科學股份有限公司 Cot 調節劑及其使用方法
US11560366B2 (en) 2019-10-21 2023-01-24 Board Of Regents, The University Of Texas System Bicyclo[1.1.1]pentane inhibitors of dual leucine zipper (DLK) kinase for the treatment of disease
AU2021249010B2 (en) 2020-03-30 2024-09-26 Gilead Sciences, Inc. Solid forms of (S)-6-(((1-(bicyclo[1.1.1]pentan-1-yl)-1H-1,2,3-triazol-4-yl)2-methyl-1-oxo-1,2- dihydroisoquinolin-5-yl)methyl)))amino)8-chloro-(neopentylamino)quinoline-3-carb onitrile a cot inhibitor compound
JP7446475B2 (ja) 2020-04-02 2024-03-08 ギリアード サイエンシーズ, インコーポレイテッド Cot阻害剤化合物を調製するためのプロセス
US20230322573A1 (en) * 2020-08-14 2023-10-12 Board Of Regents, The University Of Texas System Catalytically enhanced production of aluminum chlorohydrates
CN113264843B (zh) * 2021-04-15 2022-09-27 台州学院 一种3-氨基二环[1.1.1]戊烷-1-羧酸酯类衍生物的合成方法
CN114591137B (zh) * 2022-05-10 2022-09-09 上海赛默罗生物科技有限公司 螺桨烷类衍生物的合成方法

Family Cites Families (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US136399A (en) * 1873-03-04 Improvement in clamps for cigar-molds
IL54795A (en) 1978-05-26 1980-10-26 Yeda Res & Dev Analgesic compositions comprising substituted bicyclic and spiroaliphatic amines and certain novel compounds of these types
EP0449831A4 (en) * 1988-06-03 1992-05-20 Board Of Regents The University Of Texas System Compounds and methods based on 1.1.1)propellane
AU626949B2 (en) 1988-12-06 1992-08-13 Warner-Lambert Company 2-amino-4 or 5-methoxycyclohexyl amides useful as analgesics
US5262417A (en) 1988-12-06 1993-11-16 The Upjohn Company Antibacterial quinolone compounds
JPH04502317A (ja) 1988-12-06 1992-04-23 ジ・アップジョン・カンパニー 抗菌性キノロン化合物
JP2672205B2 (ja) * 1991-05-21 1997-11-05 富士写真フイルム株式会社 イエロー色素形成カプラー及びこれを含有するハロゲン化銀カラー写真感光材料
US5404550A (en) 1991-07-25 1995-04-04 Tandem Computers Incorporated Method and apparatus for executing tasks by following a linked list of memory packets
JPH07110559A (ja) * 1993-10-12 1995-04-25 Fuji Photo Film Co Ltd ハロゲン化銀カラー写真感光材料
JP3665567B2 (ja) 1998-03-17 2005-06-29 ファイザー・プロダクツ・インク ビシクロ[2.2.1]ヘプタンおよび関連化合物
AU3898000A (en) 1999-03-19 2000-10-09 Knoll Pharmaceutical Company Treatment of neuropathic pain or fibromyalgia
DE10025946A1 (de) 2000-05-26 2001-11-29 Gruenenthal Gmbh Wirkstoffkombination
WO2001091736A2 (en) 2000-05-31 2001-12-06 Warner-Lambert Company Combinations of an endothelin receptor antagonist and an antiepileptic compound having pain alleviating properties or analgesic
EA010132B1 (ru) 2003-12-22 2008-06-30 Пфайзер Инк. Производные триазола в качестве антагонистов вазопрессина
EP1789028A2 (en) 2004-08-24 2007-05-30 Neuromolecular Pharmaceuticals Inc Compositions for treating nociceptive pain
US9445025B2 (en) 2006-01-27 2016-09-13 Affymetrix, Inc. System, method, and product for imaging probe arrays with small feature sizes
US7763607B2 (en) 2006-04-27 2010-07-27 Solvay Pharmaceuticals Gmbh Pharmaceutical compositions comprising CBx cannabinoid receptor modulators and potassium channel modulators
JP2008120797A (ja) 2006-10-19 2008-05-29 Dainippon Sumitomo Pharma Co Ltd N−置換フェニルアセトアミド誘導体からなる医薬
RU2468011C2 (ru) 2006-12-27 2012-11-27 Санофи-Авентис Замещенные циклоалкиламином производные изохинолина и изохинолинона
US20100093696A1 (en) 2007-02-06 2010-04-15 Pfizer Inc. 2-amino pyrimidine compounds
DK2217597T3 (da) 2007-10-01 2011-06-20 Comentis Inc Quinuclidin-4-ylmethyl-1h-indol-3-carboxylatderivater som alpha-7-nicotin-acetylcholin-receptor-ligander til behandling af Alzheimers sygdom
TW201010997A (en) 2008-06-18 2010-03-16 Pfizer Ltd Nicotinamide derivatives
CA2771710A1 (en) 2009-09-18 2011-03-24 Zalicus Pharmaceuticals Ltd. Aryl sulphone derivatives as calcium channel blockers
CA2804147A1 (en) 2010-06-30 2012-01-05 Upsher-Smith Laboratories, Inc. Sustained release composition comprising an amine as active agent and a salt of a cyclic organic acid
RU2013120966A (ru) 2010-10-08 2014-11-20 Эббви Инк. ФУРО[3,2-d]ПИРИМИДИНОВЫЕ СОЕДИНЕНИЯ
TW201305178A (zh) 2010-10-29 2013-02-01 Glenmark Pharmaceuticals Sa 作為mPGES-1抑制物的三環化合物
ES2581848T3 (es) 2011-04-05 2016-09-07 Pfizer Limited Derivados de pirrolo[2,3-d]pirimidina como inhibidores de quinasas relacionadas con tropomiosina
SMT202400031T1 (it) 2011-04-22 2024-03-13 Signal Pharm Llc Diamminocarbossammide e diamminocarbonitrile pirimidine sostituite, loro composizioni e metodi di trattamento con esse
MY162167A (en) 2011-04-22 2017-05-31 Pfizer Substituted acetyl-coa carboxylase inhibitors
AU2012295802B2 (en) 2011-08-12 2017-03-30 Nissan Chemical Industries, Ltd. Tricyclic heterocyclic compounds and JAK inhibitors
JP6053505B2 (ja) 2012-01-18 2016-12-27 キヤノン株式会社 固体撮像装置
US9493481B2 (en) 2012-02-23 2016-11-15 Vanderbilt University Substituted 5-aminothieno[2,3—C]pyridazine-6-carboxamide analogs as positive allosteric modulators of the muscarinic acetylcholine receptor M4
WO2013131018A1 (en) 2012-03-02 2013-09-06 Zalicus Pharmaceuticals Ltd. Biaryl inhibitors of the sodium channel
CA2870240A1 (en) 2012-04-27 2013-10-31 Nippon Zoki Pharmaceutical Co., Ltd. Analgesic
KR102243637B1 (ko) 2013-03-14 2021-04-26 리커리엄 아이피 홀딩스, 엘엘씨 바이사이클릭 진통 화합물
WO2014169226A2 (en) 2013-04-12 2014-10-16 Philadelphia Health & Education Corporation D/B/A Drexel University Of Medicine Methods of diagnosing and treating chronic pain
DK3013805T3 (en) 2013-06-28 2018-04-23 Evotec Int Gmbh Sulfoximine-substituted quinazolines and their use as MNK1 and / or MNK2 kinase inhibitors
US9579324B2 (en) 2013-07-11 2017-02-28 Agios Pharmaceuticals, Inc Therapeutically active compounds and their methods of use
JP6211195B2 (ja) 2013-08-12 2017-10-11 エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft 呼吸器合胞体ウイルス感染症の処置および予防のための新規アザ−オキソ−インドール
BR112016008632A8 (pt) 2013-10-21 2020-03-17 Merck Patent Gmbh compostos de heteroarila como inibidores de btk, seus usos, e composição farmacêutica
CN103588668A (zh) 2013-10-28 2014-02-19 史克勇 化合物
CN103588672A (zh) 2013-10-28 2014-02-19 史克勇 一种治疗癌性疼痛的药物
CN108947867A (zh) * 2013-12-12 2018-12-07 卡利拉制药公司 双环烷基化合物及合成
EP3082819B1 (en) 2013-12-20 2020-06-17 Signal Pharmaceuticals, LLC Substituted diaminopyrimidyl compounds, compositions thereof, and methods of treatment therewith
CA2942144C (en) 2014-03-07 2023-08-22 Kalyra Pharmaceuticals, Inc. Propellane derivates and synthesis
US20150291606A1 (en) 2014-04-11 2015-10-15 The University Of North Carolina At Chapel Hill Mertk-specific pyrrolopyrimidine compounds
US20170197939A1 (en) 2014-04-15 2017-07-13 Pfizer Inc. Tropomyosin-Related Kinase Inhibitors Containing Both A 1H-Pyrazole And A Pyrimidine Moiety
EP3134397A1 (en) 2014-04-24 2017-03-01 Novartis AG Amino pyrazine derivatives as phosphatidylinositol 3-kinase inhibitors
CN107001283B (zh) 2014-07-31 2021-05-25 国家健康与医学研究院 Flt3受体拮抗剂
CN106999451B (zh) 2014-09-17 2021-04-02 里科瑞尔姆Ip控股有限责任公司 双环化合物

Similar Documents

Publication Publication Date Title
JP2017508796A5 (https=)
JP2017501218A5 (https=)
JP2010529212A5 (https=)
EP1886702A3 (de) Implantat aus einem biokorrodierbaren metallischen Werkstoff mit einer Beschichtung aus einer Organosiliziumverbindung
JP2008504264A5 (https=)
JP2012528865A5 (https=)
RU2014117188A (ru) Способ получения производных 4,4-дифтор-3,4-дигидроизохинолина
ATE526298T1 (de) Verfahren zur herstellung organischer verbindungen durch eine übergangsmetall- katalysierte kreuzkupplungsreaktion einer aryl-x-,heteroaryl-x-, cycloalkenyl-x- oder alkenyl-x- verbindung mit einem alkyl-, alkenyl-, cycloalkyl-oder cycloalkenylhalogenid
WO2008152138A3 (de) Verfahren zur herstellung difluormethylsubstituierter pyrazolverbindungen
CA2942144A1 (en) Propellane derivates and synthesis
JP2009242399A5 (https=)
DE602005009608D1 (de) Azobarbitursäuremetallkomplex sowie Verfahren zu dessen Herstellung
EP2022792A8 (en) Novel compound having affinity to amyloid
EP3381895B1 (en) Method for producing carboxylic acid thioester
WO2009008447A1 (ja) 触媒組成物及びそれを用いたクロスカップリング化合物の製造方法
TW200643053A (en) Organoaluminum precursor compounds
WO2007009637A3 (de) Deren verwendung als kontrastmittel zur anwendung in der nmr-, rontgen- und radiodiagnostik sowie in der radiotheraphie
MX2008002068A (es) Proceso de fluorinado de derivados de anilida y derivados de fluorinado de benzotiazole en la forma de agentes de generacion de imagen in vivo.
JP2008505163A5 (https=)
ATE555088T1 (de) Verfahren zur herstellung einer heterocyclischen mercaptoverbindung
Murzakova et al. A new method for the synthesis of N-substituted 1, 3, 5-dithiazinanes via the catalytic recyclization of 1, 3, 5-trithiane with aryl (benzyl) hydrazines and aryl amines
RU2008150982A (ru) Способ получения ультрадисперсного порошка металла
TW200500496A (en) Electroless gold plating solution
JP2012096999A (ja) ニッケル触媒を用いたカップリング法によるフェニル置換複素環誘導体の製造法
RU2016149299A (ru) Фторалкилирующий агент